Denali Therapeutics (DNLI)COFO and Secretary sold ~$40K
Alexander O. Schuth, COFO and Secretary at Denali Therapeutics, sold ~$40K of Denali Therapeutics shares.
- ~$40K
- Approx. value · 2,937 sh @ $13.58
- 242K
- Holds after · shares reported
- Traded
- Aug 12, 2025
- Filed
- Aug 15, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 9, 2025InsiderCEO sold ~$7.43M of DNLI shares in the open market
- Aug 12, 2025 · this disclosureInsiderOfficer sold ~$40K of DNLI shares in the open market
What came next
- Aug 12, 2025InsiderOfficer sold ~$40K of DNLI shares in the open market
- Aug 13, 2025InsiderOfficer sold ~$12K of DNLI shares in the open market
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Dec 4, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
- Dec 9, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Denali Therapeutics
OQRO holds no insider, Congress, fund or contract record for Denali Therapeutics dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DNLI page.
Other recent filings by Alexander O. Schuth, COFO and Secretary
- SEC Form 4 at Denali Therapeutics (DNLI)Jan 9, 2025
- SEC Form 4 at Denali Therapeutics (DNLI)Jan 9, 2025
- SEC Form 4 at Denali Therapeutics (DNLI)Nov 12, 2024
- SEC Form 4 at Denali Therapeutics (DNLI)Nov 12, 2024
- SEC Form 4 at Denali Therapeutics (DNLI)Nov 12, 2024
The full history of Alexander O. Schuth, COFO and Secretary is on the profile page.
How this filing works
Other disclosures at Denali Therapeutics
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 4Aug 15, 2025
- SEC Form 4Aug 15, 2025
- SEC Form 4Jul 11, 2025
- SEC Form 13F-HRMay 23, 2025
Everything OQRO holds on this company is on its DNLI page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
